Clinical Trials for Pfizer

Explore 473 clinical trials worldwide

Showing 1-50 of 473 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Pfizer

Clinical Trials (473)

NCT06873191
A Study to Learn More About Tukysa Once it is Out in the Korean Market
N/ANot yet recruiting
600 participants
Started: Dec 1, 2026 · Completed: Jun 30, 2030
2 conditions1 sponsor0 locations
NCT06832865
ELISA in Relapsed/Refractory MM
PHASE2Not yet recruiting
30 participants
Started: Aug 1, 2026 · Completed: Dec 1, 2028
2 conditions3 sponsors2 locations
NCT06507904
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
PHASE1Not yet recruiting
52 participants
Started: Apr 17, 2026 · Completed: Oct 31, 2026
1 condition1 sponsor0 locations
NCT06864585
A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan
N/ANot yet recruiting
59 participants
Started: Mar 15, 2026 · Completed: Mar 30, 2029
1 condition1 sponsor0 locations
NCT07123090
A Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
PHASE2Not yet recruiting
25 participants
Started: Feb 28, 2026 · Completed: Feb 1, 2028
6 conditions2 sponsors2 locations
NCT06983691
Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib
NANot yet recruiting
26 participants
Started: Jan 31, 2026 · Completed: Oct 31, 2026
1 condition2 sponsors0 locations
NCT04982848
Korea Post Marketing Surveillance (PMS) Study of Talzenna®
N/ANot yet recruiting
600 participants
Started: Dec 31, 2025 · Completed: Oct 31, 2026
1 condition1 sponsor0 locations
NCT07193394
Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
PHASE2Not yet recruiting
20 participants
Started: Dec 5, 2025 · Completed: Jun 8, 2029
2 conditions4 sponsors9 locations
NCT06807281
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
PHASE3Not yet recruiting
500 participants
Started: Dec 2, 2025 · Completed: Feb 22, 2032
1 condition1 sponsor7 locations
NCT07209176
Physician- and Patient-based Barriers to NGS Testing
NANot yet recruiting
256 participants
Started: Dec 1, 2025 · Completed: Dec 1, 2026
1 condition2 sponsors0 locations
NCT06760208
A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market
N/ANot yet recruiting
660 participants
Started: Nov 28, 2025 · Completed: Oct 30, 2028
2 conditions1 sponsor1 location
NCT07197762
MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults
PHASE4Not yet recruiting
125 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT07216027
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
PHASE2Not yet recruiting
200 participants
Started: Oct 31, 2025 · Completed: Aug 23, 2027
2 conditions1 sponsor0 locations
NCT07174336
A Study of LY4064809 With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
PHASE3Not yet recruiting
920 participants
Started: Oct 31, 2025 · Completed: May 31, 2033
2 conditions2 sponsors46 locations
NCT07219615
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
PHASE2Not yet recruiting
200 participants
Started: Oct 24, 2025 · Completed: Apr 23, 2027
1 condition1 sponsor0 locations
NCT07073820
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
PHASE2Not yet recruiting
36 participants
Started: Oct 24, 2025 · Completed: Jan 8, 2029
1 condition1 sponsor0 locations
NCT07206225
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
PHASE1Not yet recruiting
294 participants
Started: Oct 20, 2025 · Completed: Jan 28, 2033
1 condition1 sponsor35 locations
NCT07215078
Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants
PHASE1Not yet recruiting
72 participants
Started: Oct 8, 2025 · Completed: May 7, 2026
1 condition1 sponsor1 location
NCT06989437
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
PHASE2/PHASE3Recruiting
982 participants
Started: Oct 3, 2025 · Completed: Dec 23, 2029
2 conditions1 sponsor12 locations
NCT07190430
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
PHASE1Recruiting
16 participants
Started: Oct 3, 2025 · Completed: Feb 16, 2026
1 condition1 sponsor1 location
NCT06899204
Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
N/ANot yet recruiting
150 participants
Started: Oct 1, 2025 · Completed: Sep 30, 2026
3 conditions1 sponsor0 locations
NCT07161687
A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.
N/ANot yet recruiting
50 participants
Started: Sep 30, 2025 · Completed: Dec 13, 2029
1 condition1 sponsor0 locations
NCT06844383
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate
PHASE2Not yet recruiting
126 participants
Started: Sep 30, 2025 · Completed: Mar 31, 2029
2 conditions4 sponsors2 locations
NCT06521762
Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis
PHASE2Recruiting
96 participants
Started: Sep 30, 2025 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
PHASE3Recruiting
680 participants
Started: Sep 29, 2025 · Completed: Mar 10, 2032
3 conditions1 sponsor6 locations
NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
PHASE3Recruiting
1,000 participants
Started: Sep 28, 2025 · Completed: Dec 8, 2034
4 conditions1 sponsor45 locations
NCT07198035
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144
PHASE1Recruiting
12 participants
Started: Sep 18, 2025 · Completed: Dec 26, 2025
1 condition1 sponsor1 location
NCT06898047
Consistency of Response With Rimegepant in Acute Treatment of Migraine
N/ANot yet recruiting
250 participants
Started: Sep 17, 2025 · Completed: May 29, 2026
1 condition1 sponsor0 locations
NCT06997081
ERd Combination Treatment in Newly Diagnosed Multiple Myeloma
PHASE2Recruiting
104 participants
Started: Sep 16, 2025 · Completed: Sep 30, 2030
1 condition2 sponsors1 location
NCT06103734
A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants
PHASE3Not yet recruiting
1,280 participants
Started: Sep 15, 2025 · Completed: Aug 2, 2027
1 condition1 sponsor0 locations
NCT07029828
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
PHASE3Recruiting
140 participants
Started: Sep 10, 2025 · Completed: Jun 26, 2030
1 condition1 sponsor4 locations
NCT07160738
A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060
PHASE1Not yet recruiting
28 participants
Started: Sep 9, 2025 · Completed: Jan 11, 2026
1 condition1 sponsor0 locations
NCT07177209
Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population
N/ANot yet recruiting
4,000 participants
Started: Sep 8, 2025 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT07172321
A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults
PHASE1Active, not recruiting
12 participants
Started: Sep 5, 2025 · Completed: Oct 29, 2025
1 condition1 sponsor1 location
NCT07152119
A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.
N/ANot yet recruiting
3,000 participants
Started: Sep 1, 2025 · Completed: Sep 23, 2030
1 condition1 sponsor0 locations
NCT05810727
Atrial Fibrillation Data Linkage Non-Interventional Study
N/ANot yet recruiting
19,388 participants
Started: Aug 31, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor0 locations
NCT07127770
A Study to Understand How the Body Processes [14C]PF-07104091 in Healthy Participants
PHASE1Not yet recruiting
9 participants
Started: Aug 28, 2025 · Completed: Nov 5, 2025
1 condition1 sponsor1 location
NCT07160244
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
PHASE3Recruiting
6,000 participants
Started: Aug 25, 2025 · Completed: Mar 2, 2029
1 condition1 sponsor23 locations
NCT07090499
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
PHASE1Recruiting
310 participants
Started: Aug 20, 2025 · Completed: Jul 8, 2029
13 conditions1 sponsor2 locations
NCT07089680
A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19
N/ANot yet recruiting
1,200 participants
Started: Aug 18, 2025 · Completed: Nov 30, 2025
1 condition1 sponsor0 locations
NCT07130097
A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants
PHASE1Not yet recruiting
34 participants
Started: Aug 14, 2025 · Completed: Nov 18, 2025
1 condition1 sponsor0 locations
NCT06994897
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults
PHASE1Recruiting
92 participants
Started: Aug 13, 2025 · Completed: Dec 8, 2027
1 condition1 sponsor1 location
NCT07122661
STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)
N/AActive, not recruiting
1 participants
Started: Aug 11, 2025 · Completed: Apr 30, 2027
5 conditions2 sponsors1 location
NCT07122986
A Study to Learn About a Vaccine Against E Coli in Healthy Adults
PHASE1Recruiting
310 participants
Started: Aug 11, 2025 · Completed: May 25, 2028
1 condition1 sponsor10 locations
NCT06974786
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
PHASE2Recruiting
100 participants
Started: Aug 8, 2025 · Completed: Apr 30, 2033
2 conditions3 sponsors3 locations
NCT07153159
A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
PHASE1Recruiting
8 participants
Started: Aug 7, 2025 · Completed: Oct 12, 2026
1 condition1 sponsor1 location
NCT07062965
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
PHASE3Recruiting
400 participants
Started: Aug 5, 2025 · Completed: Nov 4, 2030
1 condition1 sponsor8 locations
NCT07086664
A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition
PHASE1Recruiting
60 participants
Started: Aug 5, 2025 · Completed: Oct 25, 2026
1 condition1 sponsor12 locations
NCT06333899
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
EARLY_PHASE1Active, not recruiting
15 participants
Started: Aug 3, 2025 · Completed: Jun 1, 2035
9 conditions2 sponsors17 locations
NCT07029711
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
PHASE3Recruiting
225 participants
Started: Jul 31, 2025 · Completed: May 18, 2027
1 condition1 sponsor17 locations